TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Depression, Anxiety, and Stress Scale-21 (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Summary of Diabetes Self-Care Activities (SDSCA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the Diabetes Knowledge Questionnaire (DKQ - Portuguese version)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Study Composite Responder status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax: Maximum Observed Plasma Concentration for TAK-279
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast: Area Under the Plasma Concentration-Time Curve From Time 0 to the Time of the Last Quantifiable Concentration for TAK-279
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC∞: Area Under the Plasma Concentration-time Curve from Time 0 to Infinity for TAK-279
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional independence with activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Family communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Nurse managers' knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ability to differentiate between problems and polarities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Creativity behavior of first-line nurse managers
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Intrinsic work motivation among first-line nurse managers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of central venous catheter infection
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor-to-background ratio (TBR) of the fluorescence signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety and tolerability of cemsidomide
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) or recommended Phase 2 dose (RP2D) for cemsidomide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antitumor activity of cemsidomide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: biological complications
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of near-infrared fluorescent cholangiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Histological activity index (HAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Annual decline in glomerular filtration rate (GFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Body volume measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body water measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body shape measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total number of drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of unhealthy drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of delirium occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax of EDP-938 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-tlast of EDP-938 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphoric reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Time Spent in Slow Wave (Deep) and REM Sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Geriatric oral health assessment index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CVAD Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Area Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between baseline TP53m VAF in blood and CH expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of TMN for OC survivors with and without TP53m CH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Trajectories of clonal evolution and mechanisms of transformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ocular and systemic adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ocular and systemic serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change from baseline in BCVA (LogMAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric antrum area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in neurocognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in amplitude of low-frequency fluctuation (ALFF) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Disease Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of pain characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of neuropathic pain presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of sleep awakenings per night
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Measurements of respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Excitatory and inhibitory biomarkers in the anterior limbic system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: VASO-based Cerebral Blood Volume (CBV) in the anterior limbic circuit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Memory task-driven activation biomarkers (fMRI with Pattern Separation task)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cortical thickness biomarkers in the anterior limbic system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gray matter volume biomarkers in the anterior limbic system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor association with pathway activation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive outcome 1 association with pathway activation pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive outcome 2 association with pathway activation pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive outcome 3 association with pathway activation pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive outcome 4 association with pathway activation pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: joint swelling and redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Aesthetic of complete denture
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Multiorgan distress syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calgary Sleep Apnea Quality of Life Index (C-SAQLI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Short Form 36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Odds ratio (OR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MOCA
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Traumatic Birth Perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Birth Fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prenatal Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's Anxiety Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's Fear Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in clinical and endoscopic parameters of intestinal inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Opioid usage after surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Concentration of saliva cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sensitivity of Endometriosis diagnostic confirmation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of Endometriosis diagnostic confirmation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric intestinal motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visceral and subcutaneous fat quantity and deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum gluco-lipid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications (pSUAPP-S) for Patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications (pSUAPP-S) for Healthcare Professionals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time to key specific intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to completion of scenario
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of correct interventions completed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants to Complete Recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants to Complete Follow-up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Resource Requirement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Emotional distraction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Treatment satisfaction level at Baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment satisfaction level at 6 months post-index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety (proportion of patients developing Grade 3 or above adverse events)
Endpoint domain: Adverse events/effects
Primary endpoint: NPRS (numeric pain rating scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lung ultrasound score (LUS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Moderate-to-vigorous physical activity (MVPA) minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhaled isoflurane requirement (volume%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowest oxygen saturation recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: decrease of the blood lead level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of surgical adhesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intervention Appropriateness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence and severity of immunotherapy related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: High-sensitivity C-Reactive Protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False negative rate of the new DVT testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Mass Index for age z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Autism symptom severity of children using Childhood Autism rating Scale diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale of Mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale of comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with Intraprocedural Hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) and/or RP2D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with histopathological regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Frequency of any reactogenicity events after administration of seasonal LAIV
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of significant increases in nasal secretion hemagglutination (HA)-specific antibody assessed by enzyme-linked immunosorbent assay (ELISA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of instances of greater than 200 influenza-specific interferon-gamma-secreting cells per million lymphocytes as assessed by enzyme-linked immuno spot assay (ELISPOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Progression to Stage 3 T1D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Core (rectal) temperature 2 hours after birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in wound area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in CPT Performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in left ventricular end diastolic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ex vivo Immune blood cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Usefulness
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Use of family planning services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Continuation of use of contraceptive methods
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pancreatic 68Ga-exendin uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to deterioration of EORTC global health scale by at least 10 points
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in the global health scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Eye trauma cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Biopsychosocial Exercise Therapy Questionnaire (BETY-BQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Baseline in Short Form-36 (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline in Hospital Anxiety and Depression Scale (HADS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Opioid Use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cervical Dilation in Centimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Increase of anti-tetanus neutralizing antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Successful application of the intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postoperative agitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change scores of Ru-Sated Sleep Composite for overall sleep health
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change score of Pittsburgh Sleep Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change score of Sleep Hygiene Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Microbiological Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low density lipoprotein cholesterol (LDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fidelity via viewing time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fidelity via transportation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility in terms of recruitment rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility in terms of retention rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of participating in the study
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Video testing on anticoagulation initiation behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Subjective units of shame (SUS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Days Alive At Home (DAH30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post-dural-puncture headache (PDPH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competence in Evaluating Newborn Positioning and Attachment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Tumour protein synthesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: length of the procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Voice perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Automated histopathological diagnosis outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum-tolerated Radiation Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Dose-Limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of self-reported pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency between fecal gene detection kit and Drug sensitivity test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency between fecal gene detection kit and first generation sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy digestibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Color change evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability correlation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dimensional obsessive compulsive symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Annualized Height Velocity (AHV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of [14C]-radioactivity excreted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rubric scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Non-Suicidal Self-Injury (NSSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean logMAR Visual Acuity at 6m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperthyroidism symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in ProdromeScan Blood Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Airway complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Coughing and restlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiorespiratory polygraphy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with endometrial synechiae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Plasma fibrinogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eligible people who provide consent
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants who complete the minimum recommended minutes of app usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes